Comment to the article: Numerous factors hamper objective assessment of disease activity in axial spondyloarthritis.
作者信息
Inan Ozenc, Aytekin Ebru, Pekin Dogan Yasemin, Mutlu Ilhan Nahit, Aydemir Kübra, Oz Nuran, Sayiner Caglar Nil
机构信息
Department of Physical Medicine and Rehabilitation, Bursa City Hospital, Bursa, Türkiye.
Department of Physical Medicine and Rehabilitation, Istanbul Training and Research Hospital, Istanbul, Türkiye.
出版信息
Arch Rheumatol. 2024 Dec 18;39(4):687-688. doi: 10.46497/ArchRheumatol.2024.93654. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
Comment to the article: Numerous factors hamper objective assessment of disease activity in axial spondyloarthritis.
Arch Rheumatol. 2024 Dec 18;39(4):687-688. doi: 10.46497/ArchRheumatol.2024.93654. eCollection 2024 Dec.
2
Numerous factors hamper objective assessment of disease activity in axial spondyloarthritis.
Arch Rheumatol. 2024 Dec 12;39(4):685-686. doi: 10.46497/ArchRheumatol.2024.10842. eCollection 2024 Dec.
3
Disease Activity Assessment in Nonradiographic Axial Spondyloarthritis: Is It Time to Move Beyond the Bath Ankylosing Spondylitis Disease Activity Index or Ankylosing Spondylitis Disease Activity Score? Comment on the Article by Rusman et al.
Arthritis Rheumatol. 2021 Dec;73(12):2351-2352. doi: 10.1002/art.41905. Epub 2021 Oct 25.
4
Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?
Semin Arthritis Rheum. 2021 Dec;51(6):1147-1161. doi: 10.1016/j.semarthrit.2021.07.011. Epub 2021 Jul 9.
5
The role of upadacitinib for the treatment of axial spondyloarthritis.
Immunotherapy. 2023 Oct;15(15):1227-1237. doi: 10.2217/imt-2023-0032. Epub 2023 Sep 7.
6
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
Rheumatol Ther. 2024 Apr;11(2):331-348. doi: 10.1007/s40744-023-00633-2. Epub 2024 Feb 3.
7
Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety.
Clin Rheumatol. 2024 Aug;43(8):2391-2402. doi: 10.1007/s10067-024-07027-x. Epub 2024 Jun 14.
8
[Assessment of residual symptoms in patients with axial spondyloarthritis with low disease activity and analysis of its related factors].
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Dec 18;56(6):987-993. doi: 10.19723/j.issn.1671-167X.2024.06.007.
9
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial.
JMIR Res Protoc. 2023 Dec 27;12:e52872. doi: 10.2196/52872.
10
In response to the recent recommendations on the assessment of patients with spondyloarthritis, a translation is needed for health professionals. Comment on: "Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches" by Baillet et al. Joint Bone Spine 2020;87:405-11.
Joint Bone Spine. 2022 May;89(3):105355. doi: 10.1016/j.jbspin.2022.105355. Epub 2022 Feb 14.
本文引用的文献
1
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort.
RMD Open. 2020 Feb;6(1). doi: 10.1136/rmdopen-2019-001093.
2
Radiographic progression in non-radiographic axial spondyloarthritis.
Expert Rev Clin Immunol. 2018 Jun;14(6):525-533. doi: 10.1080/1744666X.2018.1477591. Epub 2018 May 24.
3
Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort.
Medicine (Baltimore). 2015 Jul;94(30):e1170. doi: 10.1097/MD.0000000000001170.
4
Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Ann Rheum Dis. 2015 Jun;74(6):1241-8. doi: 10.1136/annrheumdis-2014-205322. Epub 2014 Apr 9.
Zotero 插件